Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Oncologic Drugs Advisory Committee meets this week

Sep. 15, 1997

Matrix discontinues U.S. development of AccuSite

Sep. 15, 1997

Biricodar dicitrate enters phase II studies in ovarian cancer

Sep. 12, 1997

Clinical studies begin with BNP-7787

Sep. 12, 1997

Final phase I/IIa data reported on oral Panretin in APL

Sep. 11, 1997

Letrozole approved in Canada

Sep. 10, 1997

Heat treatment for liver cancer assessed in clinical trials

Sep. 10, 1997

Another Isis oligonucleotide enters clinical testing

Sep. 10, 1997

Bexxar now administered on outpatient basis

Sep. 10, 1997

GSH prevents cisplatin-induced toxicity

Sep. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...